Syndax Pharmaceuticals

Oral histone deacetylase (HDAC) inhibitor that inhibits cancer-relevant HDAC enzymes, which contribute to epigenetic alterations driving cancer growth....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Syndax Pharmaceuticals plus 6037 other startups.

Learn More About Syndax Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More